US4510159A
Expired / Lapsed
US
⏱️ 0.0 years remaining
(+)-Cyanidan-3-ol derivatives, pharmaceutical preparations that contain such compounds, and the use of the latter to treat liver or venous diseases
Assignee: Haleon CH SARL
•
Filing: 1983-05-31
•
Granted: 1985-04-09
•
Expires: 2003-05-31
Abstract
Abstract Compound of the formula <IMAGE> (I) in which R and R' represent hydrogen or an optionally substituted hydrocarbon radical or acyl radical, R1 represents hydrogen or an optionally substituted hydrocarbon radical of aliphatic or aromatic character, R2 represents hydrogen or an optionally substituted hydrocarbon radical of higher aliphatic or aromatic character, it being possible for R1 and R2 together to represent also an optionally substituted alkylene radical or an optionally substituted biphenyl-2,2'-ylene radical, whereby however, when R, R1 and R2 are hydrogen, R' cannot be methyl and salts of such compounds that contain a salt-forming grouping, and pharmaceutical compositions containing these compounds. The pharmaceutical compositions containing these compounds are particularly valuable for treating liver and veneous diseases.
Inventors
- 👤 Alban I. Albert
- 👤 Marc E. Ballenegger
- 👤 Jan C. Overeem
- 👤 Robert G. Tyson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 15:24
CPC Classifications
C; C07; C07D; C07D407/00; C07D407/02; C07D407/04; A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/357; A61K31/36; A61P; A61P1/00; A61P1/16; A61P29/00; A61P35/00; A61P35/02; A61P37/00; A61P9/00
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
176 words
A compound of the formula ##STR8## wherein R and R' independently represent hydrogen; lower alkyl which is unsubstituted or substituted by hydroxy, oxo, amino, imino, di-lower alkylamino, halo, hydroxyimino, phenylimino, nitrophenylimino, acetylimino, cyano, carboxy or lower alkylsulfinyl; lower alkenyl which is unsubstituted or substituted by carboxy, lower alkylcarboxy, nitro, methylsulfinyl or acetoxymethylthio; lower alkynyl; cycloalkyl-lower alkyl wherein cycloalkyl has 3 to 6 ring carbon atoms; cycloalkenyl-lower alkyl wherein cycloalkenyl has 5 to 6 carbon atoms; phenyl or phenyl-lower alkyl which are unsubstituted or substituted by halo, lower alkyl, lower alkoxy, nitro or di-lower alkylamino; carboxy substituted lower alkanoyl; lower alkenoyl; carboxy substituted lower alkenoyl; trifluoroacetyl; or benzoyl or benzoyl substituted by hydroxy, halo, lower alkyl or lower alkoxy; R 1 and R 2 independently represent phenyl or phenyl substituted by hydroxy, halo, lower alkyl, lower alkoxy, nitro, lower alkoxycarbonyl, lower alkanoyloxy, or dimethylamino; or R 1 and R 2 together represent biphenyl-2,2'-ylene which is unsubstituted or substituted by hydroxy, halo, lower alkyl, lower alkoxy, nitro, lower alkoxycarbonyl, lower alkanoyloxy or dimethylamino, and therapeutically acceptable salts thereof.
Claim 2
Dependent Claim
176 words
A compound of the formula ##STR8## wherein R and R' independently represent hydrogen; lower alkyl which is unsubstituted or substituted by hydroxy, oxo, amino, imino, di-lower alkylamino, halo, hydroxyimino, phenylimino, nitrophenylimino, acetylimino, cyano, carboxy or lower alkylsulfinyl; lower alkenyl which is unsubstituted or substituted by carboxy, lower alkylcarboxy, nitro, methylsulfinyl or acetoxymethylthio; lower alkynyl; cycloalkyl-lower alkyl wherein cycloalkyl has 3 to 6 ring carbon atoms; cycloalkenyl-lower alkyl wherein cycloalkenyl has 5 to 6 carbon atoms; phenyl or phenyl-lower alkyl which are unsubstituted or substituted by halo, lower alkyl, lower alkoxy, nitro or di-lower alkylamino; carboxy substituted lower alkanoyl; lower alkenoyl; carboxy substituted lower alkenoyl; trifluoroacetyl; or benzoyl or benzoyl substituted by hydroxy, halo, lower alkyl or lower alkoxy; R 1 and R 2 independently represent phenyl or phenyl substituted by hydroxy, halo, lower alkyl, lower alkoxy, nitro, lower alkoxycarbonyl, lower alkanoyloxy, or dimethylamino; or R 1 and R 2 together represent biphenyl-2,2'-ylene which is unsubstituted or substituted by hydroxy, halo, lower alkyl, lower alkoxy, nitro, lower alkoxycarbonyl, lower alkanoyloxy or dimethylamino, and therapeutically acceptable salts thereof.
Claim 3
Dependent Claim
39 words
A compound according to claim 1, wherein R and R' are hydrogen or lower alkylbenzyl, and R 1 and R 2 are phenyl or phenyl substituted by halo, nitro, lower alkoxy or lower alkanoyloxy, and therapeutically acceptable salts thereof.
Claim 4
Dependent Claim
26 words
A pharmaceutical composition for the treatment of liver or venous diseases containing an effective amount of a compound according to claim 1 and a pharmaceutical carrier.
Claim 5
Dependent Claim
11 words
A composition according to claim 3, wherein said compound is 3',4'-O,O-(diphenylmethylene)-(+)-cyanidan-3-ol.
Claim 6
Dependent Claim
11 words
A composition according to claim 3, wherein said compound is 3',4'-O,O-[di-(4"-fluorophenyl)-methylene]-(+)-cyanidan-3-ol.
Claim 7
Dependent Claim
11 words
A composition according to claim 3, wherein said compound is 3-(3-carboxypropionyl)-3',4'-O,O-(diphenylmethylene)-(+)-cyanidan-3-ol.
Claim 8
Dependent Claim
33 words
A method for the treatment of liver diseases, which comprises administering to a living body suffering from liver diseases an effective amount of a compound of formula I as claimed in claim 1.
Claim 9
Dependent Claim
33 words
A method for the treatment of venous diseases, which comprises administering to a living body suffering from venous diseases an effective amount of a compound of formula I as claimed in claim 1.
Claim 10
Dependent Claim
1 words
3',4'-O,O-(diphenylmethylene)-(+)-cyanidan-3-ol.
Claim 11
Dependent Claim
1 words
3',4'-O,O-(diphenylmethylene)-(+)-cyanidan-3-ol.
Claim 12
Dependent Claim
1 words
3',4-O,O[di-(4"-fluorophenyl)-methylene]-(+)-cyanidan-3-ol.
Claim 13
Dependent Claim
1 words
3',4-O,O[di-(4"-fluorophenyl)-methylene]-(+)-cyanidan-3-ol.
Claim 14
Dependent Claim
3 words
3-(3-carboxypropionyl)-3',4'-O,O-(diphenylmethylene)-(+)-cyanidan-3-ol sodium salt.
Claim 15
Dependent Claim
3 words
3-(3-carboxypropionyl)-3',4'-O,O-(diphenylmethylene)-(+)-cyanidan-3-ol sodium salt.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-04-08 | 1988-10-08 | 1989-04-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-04-08 | 1992-10-08 | 1993-04-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-04-08 | 1996-10-08 | 1997-04-09 | $7700.00 | Window Closed / Lapsed |